Treatment of Glucocorticoid-Induced Osteoporosis and Risk Factors for New Vertebral Fractures in Female Patients with Autoimmune Diseases
We aimed to evaluate the compliance of physicians with the 2014 guidelines of the Japanese Society for Bone and Mineral Research, for the prevention and treatment of glucocorticoid (GC) induced osteoporosis (GIO) and to investigate the risk of fracture and other associated risk factors in bisphospho...
Saved in:
| Main Authors: | Koichiro Shinoda, Hirofumi Taki |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Journal of Osteoporosis |
| Online Access: | http://dx.doi.org/10.1155/2021/5515653 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk factors for glucocorticoid induced osteoporosis in young adults
by: Helena Florez, et al.
Published: (2025-07-01) -
Glucocorticoid-induced osteoporosis
by: I. S. Dydykina, et al.
Published: (2005-02-01) -
New possibilities for the treatment of glucocorticoid-induced osteoporosis
by: I.A. Baranova
Published: (2014-05-01) -
Zebrafish models for glucocorticoid-induced osteoporosis
by: Wen-Ying Lin, et al.
Published: (2022-01-01) -
Practical evaluation of risk factors in patients with osteoporosis-induced thoracic and lumbar vertebral compression fractures requiring surgery
by: Hung Manh Do, et al.
Published: (2024-12-01)